KeyCorp Forecasts AMETEK's FY2027 Earnings (NYSE:AME)

Key Points

• KeyCorp forecasts AMETEK’s FY2027 EPS at $9.73 and FY2028 EPS at $10.61, versus the current-year consensus estimate of $8.42. The firm maintains an “Overweight” rating and a $295 price target.
• AMETEK recently reported quarterly EPS of $2.09, beating estimates of $1.99, while revenue rose 15% year over year to $2.04 billion. Management guided to third-quarter 2026 EPS of $2.08–$2.10 and full-year EPS of $8.20–$8.30.
• Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and an average price target of $266.69; institutional investors own approximately 87.43% of the company’s shares.

AMETEK, Inc. (NYSE:AME - Free Report) - Research analysts at KeyCorp issued their FY2027 earnings per share estimates for AMETEK in a note issued to investors on Wednesday, September 30th. KeyCorp analyst S. Barger forecasts that the technology company will post earnings per share of $9.73 for the year. KeyCorp currently has a "Overweight" rating and a $295.00 price target on the stock. The consensus estimate for AMETEK's current full-year earnings is $8.42 per share. KeyCorp also issued estimates for AMETEK's FY2028 earnings at $10.61 EPS.

AMETEK (NYSE:AME - Get Free Report) last released its earnings results on Tuesday, August 4th. The technology company reported $2.09 EPS for the quarter, beating the consensus estimate of $1.99 by $0.10. AMETEK had a return on equity of 16.93% and a net margin of 20.04%.The firm had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $1.95 billion. During the same quarter in the previous year, the business posted $1.78 EPS. The business's quarterly revenue was up 15.0% compared to the same quarter last year. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS.

Other research analysts have also recently issued research reports about the stock. Morgan Stanley increased their target price on shares of AMETEK from $235.00 to $245.00 and gave the stock an "equal weight" rating in a report on Friday, July 10th. DA Davidson lifted their price target on shares of AMETEK from $265.00 to $285.00 and gave the company a "buy" rating in a research note on Wednesday, August 5th. Royal Bank Of Canada boosted their price target on shares of AMETEK from $260.00 to $291.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 5th. Truist Financial raised their price objective on AMETEK from $303.00 to $316.00 and gave the company a "buy" rating in a report on Thursday, August 6th. Finally, Robert W. Baird set a $275.00 target price on AMETEK in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $266.69.

AMETEK Price Performance

NYSE AME opened at $252.17 on Monday. The company has a quick ratio of 0.76, a current ratio of 1.21 and a debt-to-equity ratio of 0.09. AMETEK has a 12-month low of $179.24 and a 12-month high of $261.16. The company has a market capitalization of $57.80 billion, a PE ratio of 36.87, a price-to-earnings-growth ratio of 2.38 and a beta of 0.96. The firm's 50 day moving average is $243.86 and its 200-day moving average is $234.32.

Institutional Investors Weigh In On AMETEK

Several hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. acquired a new position in shares of AMETEK in the second quarter valued at $4,725,928,000. Wellington Management Group LLP lifted its stake in shares of AMETEK by 7.0% during the 2nd quarter. Wellington Management Group LLP now owns 2,994,077 shares of the technology company's stock worth $724,387,000 after buying an additional 196,986 shares during the last quarter. Flossbach Von Storch SE acquired a new stake in shares of AMETEK during the 2nd quarter worth about $662,352,000. Bank of New York Mellon Corp bought a new stake in shares of AMETEK during the 2nd quarter worth about $624,725,000. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of AMETEK by 1.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,075,229 shares of the technology company's stock worth $444,788,000 after buying an additional 29,001 shares during the period. Institutional investors and hedge funds own 87.43% of the company's stock.

Insider Activity at AMETEK

In other news, insider David Hermance sold 6,608 shares of AMETEK stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $254.00, for a total transaction of $1,678,432.00. Following the completion of the transaction, the insider directly owned 42,509 shares in the company, valued at approximately $10,797,286. The trade was a 13.45% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.54% of the company's stock.

AMETEK Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Tuesday, September 15th. AMETEK's dividend payout ratio (DPR) is presently 19.88%.

AMETEK Company Profile

AMETEK, Inc NYSE: AME is a global manufacturer of industrial technology products. The company develops and produces electronic instruments and electromechanical devices used in process, industrial, aerospace, power, energy, and other specialized markets.

AMETEK's Electronic Instruments segment supplies products such as process and analytical instruments, measurement and testing equipment, power-quality monitoring systems, automation and control solutions, and equipment for aerospace and defense applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.